ctrl K

Immunovant Inc. (IMVT)

NASDAQ: IMVT · Real-Time Price · USD

15.96

-0.19 (-1.18%)

At close: May 01, 2025, 3:59 PM

16.39

2.66%

Pre-market: May 02, 2025, 07:19 AM EDT

Immunovant Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	231K	1.32M	1.23M	998K	21K	n/a	n/a
Gross Profit	-231K	-1.32M	-1.23M	-998K	-21K	n/a	n/a
Operating Income	-282.71M	-198.47M	-156.16M	-107.79M	-65.67M	-450	-136.74M
Interest Income	24.95M	7.58M	n/a	n/a	625.00	n/a	n/a
Pretax Income	-258.77M	-210.95M	-156.81M	-107.79M	-66.29M	-448	-136.74M
Net Income	-259.34M	-210.96M	-156.73M	-107.43M	-66.39M	-448	-136.74M
Selling & General & Admin	57.28M	48.02M	54.23M	39.51M	18.15M	448.00	1.48M
Research & Development	225.43M	160.26M	101.81M	68.6M	47.93M	25.73M	135.26M
Other Expenses	n/a	-253K	-781K	328K	412K	n/a	n/a
Operating Expenses	282.71M	208.28M	156.03M	108.12M	66.08M	448.00	136.74M
Interest Expense	n/a	12.48M	655K	n/a	625K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	-2.69M	n/a
Cost & Expenses	282.71M	208.28M	156.03M	108.12M	66.08M	448.00	136.74M
Income Tax Expense	567K	9K	-84K	-358K	97K	19K	n/a
Shares Outstanding (Basic)	138.1M	123.08M	109.68M	87.76M	43.2M	14.38M	10M
Shares Outstanding (Diluted)	138.1M	123.08M	109.68M	87.76M	43.2M	14.38M	10M
EPS (Basic)	-1.88	-1.71	-1.43	-1.22	-1.54	n/a	-13.68
EPS (Diluted)	-1.88	-1.71	-1.43	-1.22	-1.54	n/a	-13.67
EBITDA	-269.98M	-209.63M	-155.58M	-106.79M	-65.64M	-28.41M	n/a
EBIT	-270.21M	-210.95M	-156.81M	-107.79M	-65.67M	-448	-136.74M
Depreciation & Amortization	231K	1.32M	1.23M	998K	21K	10K	136.74M